← Leaderboards
Clinton D Lothrop
Auburn University At Auburn
$3,292,478
Attributed
$3,292,478
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $647.4K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$3,292,478 · 2
By mechanism
R24$1,691,743 · 1
R01$1,600,735 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Bone Marrow Transplantation”
- Charles A Coltman · Southwest Oncology Group$143,196,322
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- Richard L Schilsky · University Of Chicago$50,742,272
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$48,601,153
- Kenneth C Anderson · Dana-Farber Cancer Inst$34,098,561
- Bruce R. Blazar · University Of Minnesota$32,866,133
Research focus
Bone Marrow TransplantationBaseCellsResearch StudyBone MarrowCanis FamiliarisHematopoieticLaboratoriesResearch PersonnelCyclic NeutropeniaTransplantationBiochemicalProgenitorPrincipal InvestigatorMutantStem CellsBloodBiomedical ResearchFundingEnsureBone Marrow Stem CellAllelesGene TherapyHematology
Grant awards (10)
Canine Blood Disease Models and Stem Cell Resource$376,313
R24 · FY2011 · HL · contact PI
Canine Blood Disease Models and Stem Cell Resource$362,825
R24 · FY2010 · HL · contact PI
Canine Blood Disease Models and Stem Cell Resource$314,402
R24 · FY2009 · HL · contact PI
Elastase and B3A Function$311,477
R01 · FY2008 · HL · contact PI
Canine Blood Disease Models and Stem Cell Resource$302,238
R24 · FY2008 · HL · contact PI
Canine Blood Disease Models and Stem Cell Resource$335,965
R24 · FY2007 · HL · contact PI
Elastase and B3A Function$311,477
R01 · FY2007 · HL · contact PI
Elastase and B3A Function$320,781
R01 · FY2006 · HL · contact PI
Elastase and B3A Function$328,500
R01 · FY2005 · HL
Elastase and B3A Function$328,500
R01 · FY2004 · HL